(Q36960200)

17 August 2017

1 reference

title

Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults (English)

1 reference

17 August 2017

Christopher Gibbins

1

1 reference

17 August 2017

Margaret Weiss

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Current Psychiatry Reports

17 August 2017

published in

1 reference

17 August 2017

volume

9

1 reference

17 August 2017

issue

5

1 reference

17 August 2017

page(s)

420-426

1 reference

Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry

17 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-007-0055-1

The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-007-0055-1

Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-007-0055-1

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

21 January 2018

1 reference

12 December 2020

Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families.

1 reference

12 December 2020

Assessing the concordance of measures used to diagnose adult ADHD.

1 reference

12 December 2020

A guide to the treatment of adults with ADHD.

1 reference

12 December 2020

Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder

1 reference

12 December 2020

Review of clinical validation of ADHD behavior rating scales

1 reference

12 December 2020

Diagnostic controversies in adult attention deficit hyperactivity disorder

1 reference

12 December 2020

National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD)

1 reference

12 December 2020

Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry

1 reference

12 December 2020

Medication adherence in psychopharmacologically treated adults with ADHD.

1 reference

12 December 2020

Educational and occupational outcome of hyperactive boys grown up.

1 reference

12 December 2020

The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

1 reference

12 December 2020

Hyperactive children as young adults: driving abilities, safe driving behavior, and adverse driving outcomes

1 reference

12 December 2020

Parenting in mothers with and without attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder

1 reference

12 December 2020

Functional and psychosocial impairment in adults with undiagnosed ADHD.

1 reference

12 December 2020

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

1 reference

12 December 2020

A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance

1 reference

12 December 2020

Primary care treatment of attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community

1 reference

12 December 2020

Clinical assessment and treatment of attention deficit hyperactivity disorder in adults

1 reference

12 December 2020

Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms.

1 reference

12 December 2020

Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology

1 reference

12 December 2020

Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.

1 reference

12 December 2020

Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children.

1 reference

12 December 2020

The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population.

1 reference

12 December 2020

Adults with attention-deficit/hyperactivity disorder: current concepts.

1 reference

12 December 2020

Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD.

1 reference

12 December 2020

Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms

1 reference

12 December 2020

Assessment and management of attention-deficit hyperactivity disorder in adults.

1 reference

12 December 2020

Cognitive-behavioral approaches to ADHD treatment in adulthood.

1 reference

12 December 2020

10.1007/S11920-007-0055-1

Identifiers

DOI

1 reference

17 August 2017

1 reference